Matches in Nanopublications for { ?s ?p "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519184.RAQQUNW_C2SFTtEERwIcj_7eS8z9xvzwoUYA42R-CicQs130_assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519184.RAQQUNW_C2SFTtEERwIcj_7eS8z9xvzwoUYA42R-CicQs130_provenance.
- NP937208.RA-vHRE2Q1dieNQmlSgs-VKa_AaEaqbOVoX7ujOgcBNLc130_assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937208.RA-vHRE2Q1dieNQmlSgs-VKa_AaEaqbOVoX7ujOgcBNLc130_provenance.
- assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP754267.RA2RXP0BhvJdkpinZwnvLMEUIXRgbXaeT2BW3GL8KUURY130_assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754267.RA2RXP0BhvJdkpinZwnvLMEUIXRgbXaeT2BW3GL8KUURY130_provenance.
- NP754271.RA6bJPpCPfRFtsJmgDV-mIHGwnkZdgAGbP4TXDLzmuVHI130_assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754271.RA6bJPpCPfRFtsJmgDV-mIHGwnkZdgAGbP4TXDLzmuVHI130_provenance.
- assertion description "[In Down syndrome (DS) ALL and 2 non-DS BCP-ALL cell lines, CRLF2 deregulation was associated with mutations of the JAK2 pseudokinase domain, suggesting oncogenic cooperation as well as highlighting a link between non-DS ALL and JAK2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.